Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability
Authors
Keywords
Oesophageal drug-resistant cancer, Luteolin, Cancer stemness, SOX2, Epithelial-mesenchymal transition
Journal
PHARMACOLOGICAL RESEARCH
Volume 174, Issue -, Pages 105939
Publisher
Elsevier BV
Online
2021-10-15
DOI
10.1016/j.phrs.2021.105939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation
- (2019) Zhen Wang et al. ONCOGENE
- The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective
- (2019) Vishal Das et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SOX2 in development and cancer biology
- (2019) Daniel Novak et al. SEMINARS IN CANCER BIOLOGY
- Cancer stem cell (CSC) resistance drivers
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Esophageal cancer: Risk factors, genetic association, and treatment
- (2018) Fang-Liang Huang et al. Asian Journal of Surgery
- High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion
- (2018) Yiying Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition
- (2018) Tiantian Qin et al. BIOMEDICINE & PHARMACOTHERAPY
- Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics
- (2018) Kun Han et al. Scientific Reports
- Crosstalk in cancer resistance and metastasis
- (2018) Saeed Norouzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Epithelial-mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation
- (2018) Hanmin Wang et al. DEVELOPMENTAL DYNAMICS
- Targeting SOX2 in anticancer therapy
- (2018) Laura Hüser et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting Cancer Stem Cells to Overcome Chemoresistance
- (2018) Toni Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1–SOX2 positive-feedback loop
- (2018) Jun Wang et al. NATURE NEUROSCIENCE
- Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
- (2018) Sara R. Martins-Neves et al. PHARMACOLOGICAL RESEARCH
- SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop
- (2017) Chun-Ping Cui et al. GUT
- Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study
- (2017) Yuan Liu et al. Journal of Proteomics
- Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells
- (2017) Jinxi He et al. Molecular Medicine Reports
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer
- (2017) D. Wang et al. SEMINARS IN CANCER BIOLOGY
- Overview of Cancer Stem Cells and Stemness for Community Oncologists
- (2017) Justin D. Lathia et al. Targeted Oncology
- The dark side of SOX2: cancer - a comprehensive overview
- (2017) Erin L. Wuebben et al. Oncotarget
- Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells
- (2016) PEI-HSUN TSAI et al. ANTICANCER RESEARCH
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Esophageal Cancer
- (2016) Benjamin R. Alsop et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Esophageal cancer: The latest on chemoprevention and state of the art therapies
- (2016) Gregoire F. Le Bras et al. PHARMACOLOGICAL RESEARCH
- TGF-βinduces SOX2 expression in a time-dependent manner in human melanoma cells
- (2016) Kasia Weina et al. Pigment Cell & Melanoma Research
- Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
- (2015) A O Pisco et al. BRITISH JOURNAL OF CANCER
- The challenge of targeting metastasis
- (2015) Isaiah J. Fidler et al. CANCER AND METASTASIS REVIEWS
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling
- (2015) Hui Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway
- (2015) Yang Li et al. TUMOR BIOLOGY
- Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review
- (2014) Ashok Kumar Pandurangan et al. Asian Pacific Journal of Cancer Prevention
- Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy
- (2014) K. Kemper et al. CANCER RESEARCH
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
- (2014) Soufiane Boumahdi et al. NATURE
- A Phase II Study on Continuous Infusional Paclitaxel and 5-Fu as First-line Chemotherapy for Patients with Advanced Esophageal Cancer
- (2013) Ming Gu et al. Asian Pacific Journal of Cancer Prevention
- Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells
- (2013) Cong-Chong Yang et al. BMC CANCER
- SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway
- (2013) Yasuyuki Gen et al. CANCER SCIENCE
- Establishment and characterization of a paclitaxel-resistant human esophageal carcinoma cell line
- (2013) CONG WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Increased Nanog Expression Promotes Tumor Development and Cisplatin Resistance in Human Esophageal Cancer Cells
- (2012) Li Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma
- (2010) Yasuyuki Gen et al. CANCER GENETICS AND CYTOGENETICS
- Embryonic stem cell markers expression in cancers
- (2009) Matthieu Schoenhals et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs
- (2009) Vasundhra Kashyap et al. STEM CELLS AND DEVELOPMENT
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
- (2008) Amancio Carnero et al. CURRENT CANCER DRUG TARGETS
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started